Patents by Inventor Tadimeti Rao

Tadimeti Rao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Piperidine inhibitors of Janus kinase 3
    Patent number: 9856261
    Abstract: The present invention relates to new piperidine inhibitors of Janus kinase 3 activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: January 2, 2018
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2
    Patent number: 9585884
    Abstract: The present invention relates to new pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: December 16, 2013
    Date of Patent: March 7, 2017
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • CYCLOPROPYL MODULATORS OF P2Y12 RECEPTOR
    Publication number: 20170002015
    Abstract: The present invention relates to new cyclopropyl modulators of P2Y12 receptor activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: September 16, 2016
    Publication date: January 5, 2017
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • QUINOLONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2
    Publication number: 20160376255
    Abstract: The present invention relates to new quinolone inhibitors of lipoprotein-associated phospholipase A2 activity, pharmaceutical compositions thereof, and methods of use thereof
    Type: Application
    Filed: September 9, 2016
    Publication date: December 29, 2016
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • Quinolone inhibitors of lipoprotein-associated phospholipase A2
    Patent number: 9512104
    Abstract: The present invention relates to new quinolone inhibitors of lipoprotein-associated phospholipase A2 activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: October 1, 2013
    Date of Patent: December 6, 2016
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • PIPERIDINE INHIBITORS OF JANUS KINASE 3
    Publication number: 20160340361
    Abstract: The present invention relates to new piperidine inhibitors of Janus kinase 3 activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: August 5, 2016
    Publication date: November 24, 2016
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • Cyclopropyl modulators of P2Y12 receptor
    Patent number: 9498481
    Abstract: The present invention relates to new cyclopropyl modulators of P2Y12 receptor activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: November 22, 2016
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • Piperidine inhibitors of Janus kinase 3
    Patent number: 9493469
    Abstract: The present invention relates to new piperidine inhibitors of Janus kinase 3 activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: January 14, 2015
    Date of Patent: November 15, 2016
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • OXINDOLE INHIBITORS OF TYROSINE KINASE
    Publication number: 20160257648
    Abstract: The present invention relates to new oxindole inhibitors of tyrosine kinase, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: November 9, 2015
    Publication date: September 8, 2016
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • CYCLOPROPYL MODULATORS OF P2Y12 RECEPTOR
    Publication number: 20160193212
    Abstract: The present invention relates to new cyclopropyl modulators of P2Y12 receptor activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: December 21, 2015
    Publication date: July 7, 2016
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • 4,6-DIAMINOPYRIMIDINE STIMULATORS OF SOLUBLE GUANYLATE CYCLASE
    Publication number: 20160122347
    Abstract: The present invention relates to new 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: January 11, 2016
    Publication date: May 5, 2016
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
    Patent number: 9260424
    Abstract: The present invention relates to new 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase, pharmaceutical compositions thereof, and methods of use thereof
    Type: Grant
    Filed: October 25, 2010
    Date of Patent: February 16, 2016
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • Cyclopropyl modulators of P2Y12 receptor
    Patent number: 9255104
    Abstract: The present invention relates to new cyclopropyl modulators of P2Y12 receptor activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: February 9, 2016
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • PIPERIDINE INHIBITORS OF JANUS KINASE 3
    Publication number: 20150322070
    Abstract: The present invention relates to new piperidine inhibitors of Janus kinase 3 activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: January 14, 2015
    Publication date: November 12, 2015
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • OXINDOLE INHIBITORS OF TYROSINE KINASE
    Publication number: 20150284327
    Abstract: The present invention relates to new oxindole inhibitors of tyrosine kinase, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: April 4, 2014
    Publication date: October 8, 2015
    Applicant: Auspex Pharmaceuticals, Inc.
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • Aminothiazole modulators of beta-3-adrenoreceptor
    Patent number: 9029407
    Abstract: The present invention relates to new aminothiazole modulators of beta-3-adrenoreceptor activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: June 19, 2013
    Date of Patent: May 12, 2015
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • QUINOLONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2
    Publication number: 20150094331
    Abstract: The present invention relates to new quinolone inhibitors of lipoprotein-associated phospholipase A2 activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: October 1, 2013
    Publication date: April 2, 2015
    Applicant: Auspex Pharmaceuticals, Inc.
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • Piperidine inhibitors of janus kinase 3
    Patent number: 8962638
    Abstract: The present invention relates to new piperidine inhibitors of Janus kinase 3 activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: February 24, 2015
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • CYCLOPROPYL MODULATORS OF P2Y12 RECEPTOR
    Publication number: 20140286943
    Abstract: The present invention relates to new cyclopropyl modulators of P2Y12 receptor activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: June 9, 2014
    Publication date: September 25, 2014
    Inventors: Tadimeti Rao, Chengzhi Zhang
  • Cyclopropyl modulators of P2Y12 receptor
    Patent number: 8802850
    Abstract: The present invention relates to new cyclopropyl modulators of P2Y12 receptor activity, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: July 27, 2010
    Date of Patent: August 12, 2014
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Tadimeti Rao, Chengzhi Zhang